IL82579A0 - Immunoglobulin conjugates - Google Patents

Immunoglobulin conjugates

Info

Publication number
IL82579A0
IL82579A0 IL82579A IL8257987A IL82579A0 IL 82579 A0 IL82579 A0 IL 82579A0 IL 82579 A IL82579 A IL 82579A IL 8257987 A IL8257987 A IL 8257987A IL 82579 A0 IL82579 A0 IL 82579A0
Authority
IL
Israel
Prior art keywords
immunoglobulin conjugates
conjugates
immunoglobulin
Prior art date
Application number
IL82579A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL82579A0 publication Critical patent/IL82579A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL82579A 1986-05-27 1987-05-19 Immunoglobulin conjugates IL82579A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86718386A 1986-05-27 1986-05-27

Publications (1)

Publication Number Publication Date
IL82579A0 true IL82579A0 (en) 1987-11-30

Family

ID=25349292

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82579A IL82579A0 (en) 1986-05-27 1987-05-19 Immunoglobulin conjugates

Country Status (13)

Country Link
EP (1) EP0247792A3 (de)
JP (1) JPS62287000A (de)
KR (1) KR900006908B1 (de)
CN (1) CN87104430A (de)
AU (1) AU600727B2 (de)
CA (1) CA1288896C (de)
DK (1) DK260687A (de)
HU (1) HUT44033A (de)
IL (1) IL82579A0 (de)
NZ (1) NZ220441A (de)
PT (1) PT84932B (de)
SU (1) SU1561825A3 (de)
ZA (1) ZA873600B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728856D0 (en) * 1987-12-10 1988-01-27 Bradwell A R Tumour-locating agents & method of locating tumours
IL89043A0 (en) * 1988-01-27 1989-08-15 Lilly Co Eli Antibody conjugates
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5010176A (en) * 1988-11-10 1991-04-23 Eli Lilly And Company Antibody-drug conjugates
AU5252090A (en) * 1989-04-04 1990-10-11 Eli Lilly And Company Improvements in and relating to pharmaceutical formulations
AU648313B2 (en) * 1990-04-25 1994-04-21 Pharmacia & Upjohn Company Novel CC-1065 analogs
JP2000506494A (ja) * 1995-10-18 2000-05-30 メルク エンド カンパニー インコーポレーテッド 良性前立腺過形成の治療に有用な複合体
EP1389209B1 (de) 2001-04-24 2009-04-08 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
US7910594B2 (en) 2002-05-15 2011-03-22 Endocyte, Inc. Vitamin-mitomycin conjugates
AR042942A1 (es) 2003-01-27 2005-07-06 Endocyte Inc Conjugados de administracion de drogas de union de receptores de vitaminas
EP1789391B1 (de) 2004-07-23 2017-06-28 Endocyte, Inc. Zweiwertige linker und konjugate davon
CN101175757B (zh) 2005-03-16 2012-11-14 恩多塞特公司 蝶酸及其缀合物的合成和纯化
WO2007022493A2 (en) 2005-08-19 2007-02-22 Endocyte, Inc. Ligand conjugates of vinca alkaloids, analogs, and derivatives
CN103893778A (zh) 2005-08-19 2014-07-02 恩多塞特公司 多药物配体缀合物
WO2008101231A2 (en) 2007-02-16 2008-08-21 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
JP5829793B2 (ja) 2007-03-14 2015-12-09 エンドサイト・インコーポレイテッドEndocyte, Inc. 結合性リガンドが結合したツブリシンの薬剤送達結合体
WO2009002993A1 (en) 2007-06-25 2008-12-31 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
WO2013126797A1 (en) 2012-02-24 2013-08-29 Purdue Research Foundation Cholecystokinin b receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
EP2908818A4 (de) 2012-10-16 2016-07-13 Endocyte Inc Wirkstofffreisetzungskonjugate mit unnatürlichen aminosäuren und verfahren zur verwendung
CN108948128B (zh) * 2018-07-02 2021-10-01 中国科学技术大学 一种基于缺电子苯甲醛的无催化剂腙连接多肽或蛋白质化学修饰方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI820020A7 (fi) * 1981-01-12 1982-07-13 Lilly Industries Ltd Immunoglobuliinikonjugaatteja.
EP0121388B1 (de) * 1983-03-30 1990-06-13 Lilly Industries Limited Immunoglobulinkonjugate
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
ATE89567T1 (de) * 1985-11-12 1993-06-15 Wallone Region Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
CN87104430A (zh) 1988-05-11
DK260687D0 (da) 1987-05-22
JPS62287000A (ja) 1987-12-12
KR870011132A (ko) 1987-12-21
EP0247792A2 (de) 1987-12-02
AU600727B2 (en) 1990-08-23
DK260687A (da) 1987-11-28
PT84932A (en) 1987-06-01
SU1561825A3 (ru) 1990-04-30
AU7334987A (en) 1987-12-03
PT84932B (pt) 1990-02-08
HUT44033A (en) 1988-01-28
ZA873600B (en) 1988-12-28
CA1288896C (en) 1991-09-10
NZ220441A (en) 1989-09-27
KR900006908B1 (ko) 1990-09-24
EP0247792A3 (de) 1989-07-12

Similar Documents

Publication Publication Date Title
GB2197322B (en) Antibodies
ZA864229B (en) Antibody conjugates
IL84842A0 (en) Immunoglobulin conjugates
AU98131S (en) Sealer
EP0262876A3 (en) Nucleoside-phospholipid conjugate
GB2175588B (en) Nucleoside-phospholipid conjugates
GB8400653D0 (en) Conjugates
ZA873600B (en) Immunoglobulin conjugates
GB2197323B (en) Antibodies
GB2203154B (en) Immunoglobulin conjugates
ZA89524B (en) Antibody conjugates
ZA881715B (en) Immunoglobulin conjugates
GB8710074D0 (en) Antibodies
AU99796S (en) Sealer
IE861508L (en) Antibody conjugates
GB8625461D0 (en) Conjugates
GB8619491D0 (en) Linkage
GB8623088D0 (en) Antibodies
GB8620589D0 (en) Antibodies
GB8610318D0 (en) Antibodies
GB8619998D0 (en) Antibodies
IE852244L (en) Polymeric-enzyme/antibody conjugate
IE832444L (en) Analyte-cytolysin conjugates
IE871368L (en) Immunoglobin conjugates
GB8621240D0 (en) Antigens